News & Articles
Latest news and informative articlesNews
Clinical Trials Update: COVID-19
COVID-19 & much more in our latest Industry Update
Clinical Monitoring – Why work with our Team?
Clinical monitoring shouldn’t be difficult and in the hands of our expert team, you’ll be set up in no time.
Mark Baillet – A View from the Biometrics Managing Director’s Office
COVID-19 Vaccines trials …
Science Will Prevail: Vaccines, BCs & COVID-19
AJ de Montjoie reflects on the CDISC Interchange and reviews the main presentations.
Swiss-exit, Turkey-exit, BREXIT and Medical Device Regulation
Swiss-exit, Turkey-exit, BREXIT and Medical Device Regulation
EU Medical Devices Regulation: 26 May 2021
Pegah Kiani, Director of Quality Assurance and Medical Devices, highlights what you need to know.
S-cubed Welcomes New Consultants
In both Denmark and the UK, over the last quarter, we have added new members of staff to our teams.
CDISC Interchange Europe in a Virtual World
Last year, CDISC had to turn a face-to-face Interchange in Europe to a virtual one in matter of weeks. How will this year shape up?
World Kidney Day – A Personal Story
AJ de Montjoie talks about the reasons for working in clinical research.
LOINC Codes and CDISC Lab Data – A Practical View
What do you know about LOINC? Niels Both gives a personal view of what you need to know.
S-cubed Biometrics’ Mark Baillet: Why Choose Us?
Mark Baillet discusses why S-cubed is a good partner for your trial.
Regulations & Guidance: Clinical Trials
Q1’s Industry Insights round up all the latest regulatory news
Data Optimisation with Qlik: Saving Time and Money
S-cubed’s Qlik team can have you optimising data in no time.
Women in Science: A Celebration
S-cubed Celebrates International Women in Science Day
Marketing Team: Expansion at S-cubed
We welcome our latest hire to the team, Tessa Wonge.
Waving Farewell to 2020 and Looking Forward to 2021
Scott McGregor reflects on 2020 and looks forward to 2021
Clinical Trials News and Regulations
Our latest Industry Update finishes the year focusing on COVID-19 & BREXIT
MHRA Post-Transition Period Information
All the information you need on the BREXIT transition direct from our Regulatory Team
Biomedical Concepts: The Time is Now
Biomedical Concepts are at the centre of the A3 Suite. Find out more …
MHRA Submissions – The UK submissions portal from 01 January 2021
Find out about the MHRA Submissions Portal by talking to our team.
Virtually Standing: The CDISC and PHUSE Challenge
Dave Iberson-Hurst and AJ de Montjoie focus on the Virtual Event experience …
Articles
Biomedical Concepts: The Time is Now
Biomedical Concepts are at the centre of the A3 Suite. Find out more …
Marketing Authorisation Holder GMP-related Responsibilities
Our latest regulatory update focuses on the responsibilities of the Marketing Authorisation Holder.
An overview of PRIME, Breakthrough Therapy & Fast Track procedures
This article provides an overview of PRIME, Breakthrough Therapy and Fast Track regulatory procedures intended to optimise the development of medicines that target an unmet medical need.
Optimising the path to commercialisation; Who can help and when?
Regulatory Affairs Expert Tony Mitchell co-authors a case study for a new IBS Drug This is case study for a joint project S-cubed worked on for a new drug for IBS – PharmaVentures was the lead company and they were providing market valuation expertise, Apex Healthcare...
INDUSTRY INSIGHTS
Sign up to receive our newsletters
The industry insights features the latest news and developments from the pharmaceutical industry.
Sign up for our newsletter
Download our latest publication
Featured in this issue of Industry Insights:
- COVID – 19 Guidance During the Pandemic
- Clinical Trial Regulation
- Medical Device Regulation
- Patient Focused Drug Development
If you want to contribute or share something that you’d like to be listed in the next issue, please feel free to contact us.